Cargando…
c-Rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells
Pancreatic ductal adenocarcinoma (PDAC) represents one of the deadliest malignancies with an overall life expectancy of 6 months despite current therapies. NF-κB signalling has been shown to be critical for this profound cell-autonomous resistance against chemotherapeutic drugs and death receptor-in...
Autores principales: | Geismann, C, Grohmann, F, Sebens, S, Wirths, G, Dreher, A, Häsler, R, Rosenstiel, P, Hauser, C, Egberts, J-H, Trauzold, A, Schneider, G, Sipos, B, Zeissig, S, Schreiber, S, Schäfer, H, Arlt, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237244/ https://www.ncbi.nlm.nih.gov/pubmed/25299780 http://dx.doi.org/10.1038/cddis.2014.417 |
Ejemplares similares
-
NF-κB/RelA controlled A20 limits TRAIL-induced apoptosis in pancreatic cancer
por: Geismann, Claudia, et al.
Publicado: (2023) -
TRAIL/NF-κB/CX3CL1 Mediated Onco-Immuno Crosstalk Leading to TRAIL Resistance of Pancreatic Cancer Cell Lines
por: Geismann, Claudia, et al.
Publicado: (2018) -
NF-κB Dependent Chemokine Signaling in Pancreatic Cancer
por: Geismann, Claudia, et al.
Publicado: (2019) -
Cytoprotection “gone astray”: Nrf2 and its role in cancer
por: Geismann, Claudia, et al.
Publicado: (2014) -
The Hepatic Microenvironment and TRAIL-R2 Impact Outgrowth of Liver Metastases in Pancreatic Cancer after Surgical Resection
por: Miarka, Lauritz, et al.
Publicado: (2019)